tirzepatide 15 mg weight loss Results were over 72 weeks. Mounjaro (Tirzapatide) is a GLP-1 + GIP, dual-acting drug. The GLP (Glucagon Like Peptide)-1 component is mainly known for appetite control, but it also: • Improves insulin Tirzepatide associated with greater weight

We make it easy to start your journey toward a healthier you with an affordable weight loss Michigan solution

The items below reflect a mix of what the research suggests and what patients commonly describe in clinical practice

Benefits of Compounded Semaglutide Found members using GLP-1 injections as part of a full Found program have reported losing up to 16% of their body weight in 12 months.* Results depend on dose, duration, and how closely you follow your care plan

Source: Baer HJ, Rozenblum R, De La Cruz BA, et al

Ongoing monitoring: Track utilization, rebates, and formulary adjustments to refine assumptions over time